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In addition to immunodeficiency, human immunodeficiency virus type 1 (HIV-1) can cause cognitive im-
pairment and dementia through direct infection of the brain. To investigate the adaptive process and timing
of HIV-1 entry into the central nervous system, we carried out an extensive genetic characterization of variants
amplified from different regions of the brain and determined their relatedness to those in lymphoid tissue.
HIV-1 genomes infecting different regions of the brain of one study subject with HIV encephalitis (HIVE) had
a mosaic structure, being assembled from different combinations of evolutionarily distinct lineages in p17gag,
pol, individual hypervariable regions of gp120 (V1/V2, V3, V4, and V5), and gp41/nef. Similar discordant
phylogenetic relationships were observed between p17gag and V3 sequences of brain and lymphoid tissue from
three other individuals with HIVE. The observation that different parts of the genome of HIV infecting a
particular tissue can have different evolutionary histories necessarily limits the conclusions that can be drawn
from previous studies of the compartmentalization of distinct HIV populations in different tissues, as these
have been generally restricted to sequence comparisons of single subgenomic regions. The complexity of viral
populations in the brain produced by recombination could provide a powerful adaptive mechanism for the
spread of virus with new phenotypes, such as antiviral resistance or escape from cytotoxic T-cell recognition
into existing tissue-adapted virus populations.
Isolates of human immunodeficiency virus (HIV) show great
heterogeneity in their kinetics of replication, coreceptor usage,
cellular tropism, and cytopathic effects. Differences in these
properties have been hypothesized to underlie in vivo differ-
ences in pathogenicity, which in turn may influence the rate of
disease progression in HIV-infected individuals (1, 2, 5, 9, 11,
16, 19, 20, 28, 40, 44). Differences in phenotype may also
underlie differences in in vivo cellular tropism, which would
substantiate the hypothesis that the different populations of
HIV infecting lymphoid tissue, brain, and other tissues may
have originated through an adaptive process following primary
infection. Difficulties in recovering HIV from nonlymphoid
tissues have to date prevented extensive analysis of their bio-
logical properties, although the existence of consistent se-
quence differences in the envelope gene from those recovered
from lymphoid tissues provides indirect evidence for specific
cellular tropisms (3, 13, 14, 17, 22, 26, 27, 30, 31, 34–36, 42).
However, an alternative hypothesis proposes that differences
in the rate of virus turnover in different cell types may lead to
the observed population differences, given the rapid temporal
change in HIV populations over time in peripheral blood
mononuclear cells, in lymph nodes (LN), and among HIV
variants recovered from the gastrointestinal tract (27, 45, 46).
To investigate whether differences in V3 and elsewhere in
the HIV genome reflect tissue adaptation, or whether they
arise simply though limited spatial or temporal sampling, we
have compared nucleotide sequences in different regions of the
HIV type 1 (HIV-1) genome from lymphoid tissue with au-
topsy samples from anatomically separated parts of the brains
of four study subjects with HIV encephalitis (HIVE). We also
determined whether sequences in p17gag, pol, and different
regions of the env gene (V1/V2, V3, V4, V5, and gp41/nef)
between different brain samples and those from lymphoid tis-
sue provided equivalent evidence for tissue-specific compart-
mentalization of HIV-1.
MATERIALS AND METHODS
Study subjects. Frozen samples of LN or spleen and from several anatomically
distinct regions of the brain from four individuals with HIV giant cell encepha-
litis were stored at autopsy (risk group, CD4 counts, and brain pathology are
summarized in Table 1). Subject NA129 had received zidovudine monotherapy
for 17 months up to approximately 1 year before death; ddC was used for 1
month, finishing 3 months before death. The other study subjects had received
minimal antiviral treatment: for NA234, a single course of zidovudine for a
duration of 1 month at 1 year before death; for NA021, zidovudine intermittently
over 1 year at 5 years before death and zidovudine-ddC for 1 month at 1 year
before death; for NA173, zidovudine for 4 months at 2 years before death and
then for 1 month at 1 year before death. None of the study subjects showed
evidence for genotypic resistance to zidovudine or other antiviral agents (42a).
Pathology examination. The brains were examined pathologically as previously
described (4). Assessment of pathology findings was undertaken blind to the
PCR analysis and validated by three independent observers.
DNA extraction and amplification. DNA was extracted from the brain, LN,
and spleen and quantified as previously described (15). Total DNA was quanti-
fied spectroscopically, while HIV proviral DNA was semiquantitated by ampli-
fication, using the p17gag primers, of serial 10-fold dilutions of DNA, with the last
positive dilution used to indicate the minimum proviral load in the sample.
Samples were used for sequence comparison only if proviral frequencies were
.100 copies/106 cells, and this excluded analysis of left parietal (LP) and both
cerebellum samples from NA234. Low levels were detected in two atrophied LN
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samples from NA128, and lymphoid sequences were therefore obtained from the
spleen. For nucleotide sequencing, 1-mg aliquots of extracted DNA were ampli-
fied as previously described (39) or amplified after dilution to an endpoint (see
below).
Amplified DNA was either sequenced directly by cycle sequencing (Amer-
sham) or cloned into pGEM, using poly(T) overhangs (pGEM-T Vector system;
Promega). Miniprepped DNA from clones was sequenced by using a Sequenase
version 2.0 kit (U.S. Biochemical) according to the manufacturer’s protocol.
Nucleotide sequencing. For samples with evidence of sequence heterogeneity,
amplified DNA was cloned and approximately 10 clones were sequenced. Se-
quences from other samples without evidence for heterogeneity (no detectable
multiple bands at any position on a sequencing gel lane) or length polymorphism
analysis (23) were directly sequenced. The sequence data set for the p17gag
region of NA234 was assembled from cloned sequences from each of the brain
regions and extended from positions 405 to 795 in the HIVLAI genomic sequence
(GenBank accession no. K02013). Sequences in the pol region of NA234 were
directly sequenced from amplified DNA and compared between bases 2189 and
2842, using the PCR primers used for detection of antiviral resistance mutations
(43); there was no evidence for intrasample sequence heterogeneity. Sequences
in the V1/V2 region from NA234 were amplified by using primers as previously
described (23). Amplified DNA was homogeneous by length polymorphism anal-
ysis, and nucleotide sequences from regions other than LN, left frontal (LF), and
right frontal (RF) were obtained by direct sequencing of amplified DNA. Se-
quences in V3 and V4/V5 were amplified by using primers as previously de-
scribed (38). Length polymorphisms in the V4/V5 region in some brain samples
from NA234 necessitated multiple clones to be sequenced. Sequences from each
tissue were amplified in the gp41/nef region by using outer primers 59-AGGGC
TGCTATTAACAAGAGATGG-39 and 59-GTAGCTGCTGTATTGCTACTT
GTG-39 and inner primers 59-AGGTCTTCAGACCTGGAGGAGG-39 and 59-
TATTGCTACTTGTGATTGCTCCATG-39 (59 base positions 7166, 8541, 7215,
and 8531, respectively). Direct sequencing was carried out on the amplified DNA
from the 39 end by using the antisense inner primer, while an internal primer
(59-TGAGGGGACAGATAGGGTTATAGA-39, position of 59 base 8287 in
HIVLAI genome) was used to sequence the 59 end.
Sequences were aligned and distances were estimated with the Simmonic 2000
Sequence Editor package. Synonymous and nonsynonymous distances and stan-
dard errors were estimated by the method of Nei and Gojobori (33). Phyloge-
netic analysis was carried out with the MEGA program (29). The nucleotide
sequences from p17gag and V3 amplified from each of the study subjects were
compared with each other and with a range of standard HIV-1 variants. Each set
of sequences from the four study subjects was monophyletic in both genomic
regions and distinct from those of the published sequences of subtype B: HIVSF2
(K02007), HIVRF (M17451), HIVOYI (M26727), HIVLAI (K02013),
HIVJRFL (M74978), HIVYU2 (M93258), HIVCAM1 (D10112), HIVNY5CG
(M38431), HIVHAN (U43131), HIVWMJ22 (M12507), and HIVSFAAA
(M65024). This comparison provided no evidence for coinfection with more than
one epidemiologically unrelated HIV strains or for intersample or exogenous
laboratory contamination.
Nucleotide sequence accession numbers. Nucleotide sequences obtained in
this study have been submitted to GenBank and assigned accession no.
AF174692 through AF175123.
RESULTS
Sequence relationships in different regions of the HIV-1
genome. Autopsy samples were obtained from multiple regions
of the brain and from LN of an individual (NA234) with au-
topsy evidence of HIVE. The p17gag region was amplified by
nested PCR and cloned from samples with virus loads of
greater than 100 proviral copies/106 cells. These nucleotide
sequences formed two distinct evolutionary lineages, each with
bootstrap support of ^80%. Sequences from LN, brain stem,
right parietal (RP) and LF regions (lineage A) showed a closer
sequence relationship to each other than to variants obtained
from elsewhere in the brain (lineage B) (Fig. 1). At synony-
mous sites, the mean pairwise Jukes-Cantor (J-C) distances
were 0.057 (mean standard error 60.026) among members of
lineage A and 0.055 (60.024) for lineage B, almost nonover-
lapping with the range of pairwise distances observed between
the two lineages (mean synonymous distance 0.109 6 0.038).
On the basis of the previously established mean rate of se-
quence change in this region of gag (0.6 to 0.7% per site per
year [24, 25]), these distances suggest a time of divergence
between lineages A and B of around 8.4 6 2.9 years, compared
with a likely duration of HIV infection of around 10 years in
this study subject.
In contrast to LN sequences, those from other regions of the
brain were relatively homogeneous, apart from those from the
RP region, which formed at least three separate clusters within
lineage A, and a single sequence from the LF region, which
grouped in lineage B instead of lineage A. Sequences in lin-
eage B, comprising exclusively brain-derived variants, clustered
by tissue origin, with a tendency for variants recovered from
adjacent tissues to be more similar to each other (e.g., left
occipital [LO) and right occipital [RO] regions) than to vari-
ants from virus with greater physical separation (e.g., occipital
region to RF region). Most regional variants in lineage B had
common ancestors distinct from any variants found in lym-
phoid tissue, and more recent times of divergence than that
between lineages A and B can be inferred. Variants within
lineage B may therefore have originated from the spread of
HIV within the brain rather than from multiple seeding from
the peripheral circulation and thus differ in origin from brain-
derived variants in lineage A (LF and RP). To confirm the
separate groupings of LF and RF sequences, DNAs extracted
from these tissues and from LN were separately analyzed by
limiting dilution as previously described (39). Sequences ob-
tained were similar or identical to those obtained by cloning of
PCR products (data not shown).
In marked contrast to the relationships observed in p17gag,
LF and RF sequences from both V1/V2 and V3 regions in
gp120 grouped together in a distinct lineage from those of LN
sequences (bootstrap support ^80%) (Fig. 2A and B), dem-
onstrating that variants from LF and RF regions shared a
common ancestor distinct from that of variants in the LN
region. The probability of this discordant phylogeny arising
through sampling was ,0.0001 (Fisher’s exact test). To inves-
tigate the robustness of the difference in branching order in
p17gag and V3, a user-defined tree of p17gag sequences with the
branching order of V3 was created by using RETREE in the
PHYLIP package (18). With the Hasegawa-Kishino-Yano test,
a p17gag tree with the V3 branching order was significantly less
TABLE 1. Clinical background and pathology appearance of study subjects
Study
subject
Age
(yr)
Risk
groupa
CD4/ml HIV-related pathologyb
Other
pathology1 yr
before death
3 mo
before death PV WM GM BG BS Cere
NA173 34 MH 1 0 11 1/2 1/2 1/2 1/2 2 Toxoplasma
NA021 49 IVDU 300 87 1 11 1 1 1/2 1/2
NA128 48 MH 12 4 1/2 111 11 11 11 2 Toxoplasma
NA234 28 IVDU 90 30 1 11 11 11 1 1 Lymphoma
a MH, male homosexual; IVDU, intravenous drug user.
b Scored as 2 (negative), 1/2 (sparse pathology) 1, (slight pathology), or 111 (severe pathology in different brain compartments). PV, perivascular; WM, white
matter; GM, grey matter; BG, basal ganglia; BS, brain stem; Cere, cerebellum.
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FIG. 1. Phylogenetic analysis of the p17gag region amplified from different regions of the brain and from lymphoid tissue of NA234. Divergence between nucleotide
sequences was estimated from J-C distances (scale indicated below tree), and the tree was constructed from the distance matrix by the neighbor-joining method. The
robustness of groupings was indicated by bootstrap resampling of 100 data sets, with values of ^75% indicated on branches; lineages are indicated by single letters.
The tree was rooted by using the sequence of HIVLAI (accession no. K02013) as an outgroup.
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FIG. 2. Comparison of sequences from LF and RF regions of the brain of NA234 with those of the LN region in V1/V2 (A), V3 (B), V4 (C), and V5 (D)
hypervariable regions (outgroup, symbols, and bootstrap method as for Fig. 1).
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likely than the most likely tree calculated by using maximum
likelihood (DNAML; P 5 0.018).
In the V4/V5 region, sequence relationships were more com-
plex and also discordant from those observed both for p17gag
and for V1/V2 or V3 (Fig. 2C, 2D, 3C, and 3D). Variants from
the LN region formed three lineages (A, B, and C), with a
fourth lineage comprising variants from the LF and RF regions
(lineage D). However, approximately half of the LF variants
grouped with lineage C. Similar sequence relationships were
observed for the V5 region, with three main lineages compris-
ing LN (A), LN and LF (B), and LF and RF (C). Because V4
and V5 sequences were amplified in the same PCR fragment,
it was also possible to observe different combinations of lin-
eages between the two regions (Fig. 3D). For example, V4
sequences of 12 LF clones were in lineage C in V4 and in
lineage B in V5 (i.e., CB), while 9 clones were DC and 7 were
CC. Similar reassortments were observed in LN sequences
(one AA, two AB, one BB, and three BC).
To investigate further the tissue distribution of variants in
different genomic regions, we obtained sequences from the pol,
V1/V2, V3, and gp41/nef regions of variants recovered from
other parts of the brain (Fig. 4). The most conserved region
was the pol region, in which sequences from different regions
of the brain did not display any significant phylogenetic group-
ings. The mean pairwise distance between pol sequences from
different samples was 0.013 (0.048 at synonymous sites), lower
than observed between variants within either lineage A or
lineage B in the p17gag region. Either there was a lower rate of
sequence change at synonymous sites in this part of the ge-
nome or the pol region of the genome originated after the
diversification of p17gag, implying the existence of recombina-
tion between the pol region and more variable regions of the
genome.
In V1/V2, we observed four bootstrap-supported lineages,
differing from each other by distances of 0.022 to 0.076, com-
pared with distances of 0 to 0.008 within lineages. The distri-
bution of sequences from different regions of brain did not
match the distribution of sequences into the two lineages in
p17gag (Fig. 3 and 4). For example, sequences from LN (A in
p17gag) and choroid plexus (CP) (B in p17gag) regions were
found in the same lineage in V1/V2, while sequences from LF
and RP regions, which grouped with the LN sequence in
p17gag, were on three separate lineages in V1/V2 (A, C, and
D).
Similar complexity was observed among sequences from V3,
V4, V5, and gp41/nef, with variants from the CP showing the
greatest diversity in V3, V4, and V5. A subpopulation of CP
variants grouped with those found in lymphoid tissue (e.g.,
lineages C in V3, B in V4 and V5, and A in gp41), but as
described above for LN and LF, there were inconsistent rela-
tionships in the V4 and V5 regions (Fig. 3C), with all four
combinations of lineages B and C in V4 and A and B in V5
being observed. Overall, no consistent relationship between
lineages was observed among the other samples collected from
the brain (Fig. 3), and apart from LO and RO regions, each
region of the brain contained a different combination of phy-
logenetically distinct subgenomic fragments.
Tissue-specific grouping. Variants from different regions of
the brain of NA234 consistently grouped separately from those
recovered from LN in the V1/V2, V3, and gp41/nef sub-
FIG. 3. (A) Distribution of phylogenetic groupings in different regions of the genome of HIV-1 variants infecting NA234. Letters refer to bootstrap-supported
groupings identified by phylogenetic analysis (Fig. 1, 2, and 3); vertical bars indicate discontinuities in groupings that require the minimum number of recombination
events. The sequence conservation and monophylogeny of the pol region originated either through recombination or from a lower rate of sequence change compared
with the rest of the genome; sequence relationships are indicated with an interrupted line to indicate this uncertainty. Three samples contained sequences distributed
in more than one clade in V4 and V5, in the combinations tabulated in LN (B), CP (C), and LF (D) regions of the brain.
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FIG. 4. Comparison of inferred amino acid sequences of variants from different regions of the brain of NA234 in V1/V2 (A), V3 (B), V4 (C), V5 (D), and gp41
(E) /nef, using LN variants as reference sequences. Horizontal lines divide primary bootstrap-supported (^75% of data sets) phylogenetic groupings of nucleotide
sequences. Each number in the third column indicates the number of clones used to create the indicated consensus sequence. c, consensus sequence obtained by direct
sequencing of PCR product. Symbols: z, sequence identity with LN sequence; -, gap introduced to presence sequence alignment; p, termination codon. Sequences are
numbered by their positions in the HIVLAI gp120 (A to D) or nef (E) sequence. BS, brain stem.
8725
genomic regions. To investigate further the differentiation be-
tween lymphoid and brain-derived variants, sequences from
the p17gag and V3 regions were obtained from 8 to 12 brain
regions from three other individuals (NA021, NA173, and
NA128) and compared with those amplified from the corre-
sponding LN or spleen samples (Table 2; Fig. 5 and 6). Se-
quences from each individual were monophyletic in both
p17gag and V3 upon comparison with each other and with
epidemiologically unlinked subtype B sequences (listed in Ma-
terials and Methods).
In each of the three study subjects, p17gag sequences of
variants infecting different regions of the brain and lymphoid
FIG. 5. Comparison of inferred amino acid sequences of variants from the V3 region of NA173 (A), NA021 (B), and NA128 (C), using the LN or spleen (SPL)
sequences as a reference. Horizontal lines divide bootstrap-supported (^75% of data sets) phylogenetic groupings of nucleotide sequences (symbols and sequence
numbering correspond to those in Fig. 4). BS, brain stem.
TABLE 2. p17gag and V3 sequence divergence
Comparison Studysubject
Distancea
p17gag V3
Mean Error Rankb Mean Error Rank
Within brain NA021 0.034 0.009 3 0.015 0.008 4
NA173 0.035 0.010 2 0.017 0.008 3
NA128 0.012 0.006 4 0.035 0.011 1
NA234 0.042 0.011 1 0.028 0.010 2
Brain-lymphoid tissue NA021 0.040 0.009 3 0.043 0.014 3
NA173 0.040 0.011 2 0.031 0.011 4
NA128 0.023 0.008 4 0.080 0.018 1
NA234 0.057 0.013 1 0.072 0.018 2
a Mean J-C distance between variants within brain or between brain and LN or spleen (excluding CP).
b Rank of variability (1 5 most variable).
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FIG. 6. Phylogenetic analysis of p17gag (column 1) and V3 sequences (column 2) of the four study subjects (A through D). Sequences from each of the four subjects
were monophyletic in both genomic regions upon comparison with each other and the sequences available from GenBank listed in Materials and Methods and were
used to root each clade. p17gag and V3 trees from different study subjects were plotted by using the indicated scale of J-C distances. Sequences were derived from brain
(F), from lymphoid tissue (LN or spleen [SPL]) (E), or from CP (h). All bootstrap values of ^75% are indicated on branches. Sequences from NA234 were obtained
from individual clones of amplified DNA instead of by direct sequencing; single representative clones from each sample or multiple clones for those containing
sequences in more than one lineage (i.e., LN and CP) have therefore been included. BS, brain stem; BG, basal ganglia.
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tissue showed interrelationships different from those observed
in V3. First, there was no correlation between sequence diver-
sity between the two genomic regions (Table 2). For example,
p17gag sequences from NA173 showed two- to threefold-
greater variability between brain regions (mean J-C distance of
0.035 6 0.010) and between brain and lymphoid tissue (mean
J-C distance of 0.04 6 0.011) than the corresponding se-
quences from NA128 (distances of 0.012 6 0.006 and 0.023 6
0.008). In contrast, sequences from NA128 in the V3 region
were more variable than those from NA173 (0.035 6 0.011 and
0.080 6 0.018, compared with mean distances of 0.017 6 0.008
and 0.031 6 0.011 for NA173).
Second, phylogenetic analysis of the p17gag and V3 se-
quences produced different groupings of variants (Fig. 6). For
example, LN sequences from NA021 clustered separately from
brain-derived variants in the V3 region but grouped with brain
variants in p17gag. Conversely, LN sequences from NA173 were
distinct from all but one of the variants in p17gag but were
undifferentiated from brain variants in V3. In each of the four
study subjects, tissue specificity depended on the region being
compared. A specific instance of incompatible phylogeny com-
parable to that observed for NA234 (see above) was observed
in NA021, where LN sequences formed a bootstrap supported
lineage in V3 distinct from the brain variants, while the pri-
mary branching order in p17gag divided sequences from the RT
and RO brain regions from the rest of the sequences.
Sequence divergence and pathology appearance. The sever-
ity of HIVE varied between the study subjects (Table 1), rang-
ing from infrequent giant cells confined to perivascular regions
(NA173) to widespread pathology affecting both white and
grey matter (NA128; Fig. 7). The extent and type of HIV-
induced pathology correlated with the degree of V3 but not
p17gag sequence diversity between different brain regions and
in the extent to which V3 sequences from the brain differed
from those in lymphoid tissue. V3 sequences from NA173
(who showed minimal HIV-related pathology) were largely
undifferentiated from those detected in LN, with only an ala-
nine-arginine change segregating by tissue (mean J-C distances
listed in Table 2). At the other extreme, the spleen-derived
sequence from NA128 had a predicted syncytium-inducing
phenotype and differed at multiple sites from the nonsyncy-
tium-inducing variants in the brain. In the p17gag region, how-
ever, sequences from NA173 were the most variable, and those
from NA128 were the least variable.
DISCUSSION
This study documents the extraordinary complexity of HIV
populations in vivo, findings which have several implications in
understanding mechanisms of tissue adaptation and the timing
of entry of HIV into the central nervous system (CNS). The
marked sequence diversity of the p17gag region and the readily
identifiable clusters of sequences in the hypervariable regions
of env (V1/V2, V3, V4, and V5) of NA234 and other study
subjects provided evidence for recombination between differ-
ent regions of the genome. For example, variants infecting
separate regions of the brain of NA234 were assembled from
two different p17gag lineages and a limited number of distinct
hypervariable region lineages, often with different combina-
tions within same autopsy sample (e.g., the V4 and V5 se-
quences in the LN, CP, and LF sequences [Fig. 3 to D]). In the
other three study subjects, the different degrees of variability
and the discordant phylogenetic groupings between p17gag and
V3 regions indicate a lack of genetic linkage between these two
subgenomic regions and further support the hypothesis of fre-
quent recombination in vivo.
To date, recombination has been most easily identified be-
tween different subtypes of HIV-1; for example, variants of
HIV-1 from Thailand contain gag sequences resembling those
of subtype A but distinct from subtype A in the env gene (7),
while other viruses appear to have been generated by multiple
recombination events (e.g., HIV-1MAL [10, 37] and subtype I
[21]). Recombination has also been observed upon infection
with different strains of HIV-1, either experimentally in a
chimpanzee exposed to the laboratory isolates HIVLAI and
HIV-1SF2 (47) or possibly through multiple exposure to two or
more sources of HIV infection in a blood recipient and an
injecting drug user (12, 49). We have now demonstrated that
recombination also occurs within an infected individual be-
tween variants descended in each case from the original infect-
ing strain. The finding that different parts of the HIV genome
can have different evolutionary histories severely limits the
concept of tissue specificity of variants of HIV in vivo, partic-
ularly if these conclusions are based on a single subgenomic
region. For example, the brain-specific and frequently mono-
phyletic nature of HIV sequences in the pol region (virodemes)
of variants infecting antiviral agent-treated individuals (48)
may not be reflected elsewhere in the genome. Indeed, se-
quence relationships in the env gene may differ substantially
from pol, as variation in the former region is more likely to
confer phenotypic differences in cellular tropism. The exis-
tence of recombination provides an explanation for discordant
phylogenies between p17gag, V1/V2, and V3 that we observed
between brain (in the LF region) and LN sequences in three
previous subjects (14, 23, 24). While sequences in V3 were
tissue specific, sequences in the p17gag and V1/V2 regions were
diverse, and some evolutionary lineages were common to vari-
ants recovered from brain, lung, and LN. Our observations
support the hypothesis that recombination may accompany the
acquisition of antiviral resistance, as exemplified by the ap-
pearance of zidovudine-resistant mutants in the peripheral cir-
culation which occurred without evidence for a comparable
bottlenecking in env (6); V3 sequences showed no reduction in
diversity during the process of population replacement in pol
region.
The diversity of V3 sequences in different brain regions of
the four study subjects was similar to a previous comparison of
variants infecting different brain regions (mean pairwise dis-
tance between brain regions, 0.021 [8], excluding sequences
from the LF region that were highly divergent in sequence and
failed to group phylogenetically with sequences derived from
other regions of the brain). The LF sequences may have orig-
inated from exogenous contamination of the PCR, or corre-
sponded to an epidemiologically unlinked isolate in a case of
mixed infection. In either case, the observed degree of se-
quence divergence was unlikely to have originated from se-
quence change over the course of infection within the study
subject.
Greater degrees of sequence complexity may also originate
from the presence of different infected cell types in a tissue
sample. HIV sequences amplified from the choroid plexus of
NA234 showed the greatest diversity in the env region, con-
taining variants corresponding to those from lymphoid tissue
and brain, consistent with the presence of virus from blood-
derived cells and brain parenchyma. The proximity of these
different cell types in the CP may provide an opportunity for
recombination of HIV to occur, as well as a site of entry of
HIV into the CNS. Without biological characterization of the
variants found in the CP or elsewhere in the brain, it remains
unclear whether recombinant genomes have been selected or
represent random samplings of phenotypically identical vi-
ruses. However, the multiple recombination events observed in
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FIG. 7. Immunocytochemical detection of p24 antigen in representative sections of cerebral white matter of two study subjects with HIVE. (A) NA173.
Immunopositive mononuclear and giant cells (stained brown with diaminobenzidine) are confined to the perivascular region. (B) NA128. Widely dispersed HIV-
infected microglia in white matter.
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this study would provide a powerful mechanism for adaptation,
providing, for example, an effective method for the spread of
antiviral agent resistance or cytotoxic T-cell escape mutants
into the CNS. Recombination between these latter determi-
nants and env could produce new virus populations that retain
their neuroadapted phenotype.
The differing sequence relationships between brain-derived
and lymphoid variants from the four study subjects suggests
that entry of HIV-1 into the CNS can occur at different times.
The current consensus view that entry occurs early during HIV
infection is supported by the observation that HIV RNA se-
quences can be detected in cerebrospinal fluid throughout the
course of infection and by the detection of low levels of HIV
proviral sequences in brains of asymptomatic individuals (4, 15,
41). Early entry is also supported by the extensive sequence
diversity in the p17gag region of variants recovered from the
brain, such as between lineages A and B observed in NA234 in
this study, which implies several years of divergent evolution
(24). However, the relevance of early entry into the CNS in the
development of late stage HIVE remains unclear, since active
virus replication has not been demonstrated immunocyto-
chemically during early infection (4), and brains show little
evidence of pathology apart from the presence of infiltrating
CD8 lymphocytes in perivascular areas.
Evidence for a contribution of late-entering variants to
HIVE is provided by NA173, who showed a distinctive pathol-
ogy appearance of HIV-expressing infiltrating macrophages
confined to the perivascular regions (Table 1; Fig. 7A). The
hypothesis of recent entry of HIV-infected cells into the brain
parenchyma was supported by the observation of close se-
quence similarity in the V3 region of brain-derived variants
with those obtained from lymphoid cells. This late-entry pic-
ture contrasted strongly with the distribution of HIV infection
in NA128, in which HIV was widely dispersed in white (Fig.
7B) and grey matter, while V3 sequences were distinct between
spleen and brain and heterogeneous within brain (Table 2; Fig.
5C). This correlation was, however, not supported by sequence
comparisons in the p17gag region, where sequence diversity was
greatest in NA173 and least in NA128.
Indeed, to understand the adaptive significance of the se-
quence differences in different parts of the genome, it will in
the future be necessary to analyze functionally the contribution
of each genomic region to the phenotype of the virus. In
particular, it will be important to determine the phenotypic
significance of recombination between the p17gag and env re-
gions, particularly as variants with different combinations of
lineages in the two regions were associated with distinct pa-
thology appearances. Understanding what contributes to neu-
rotropism will illuminate the selective pressures (if any) that
produce the recombinant viruses observed in this study. The
lack of genetic linkage in the HIV genome resulting from
recombination greatly enhances its ability to adapt to several
simultaneously acting selection pressures, as indicated by the
rapid emergence in vitro of dual antiviral agent-resistant mu-
tants (32).
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